These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11709781)

  • 21. Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy.
    Sarmati L; Nicastri E; Montano M; Dori L; Buonomini AR; d'Ettorre G; Gatti F; Parisi SG; Vullo V; Andreoni M
    J Med Virol; 2004 Apr; 72(4):511-6. PubMed ID: 14981751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.
    Finzi D; Blankson J; Siliciano JD; Margolick JB; Chadwick K; Pierson T; Smith K; Lisziewicz J; Lori F; Flexner C; Quinn TC; Chaisson RE; Rosenberg E; Walker B; Gange S; Gallant J; Siliciano RF
    Nat Med; 1999 May; 5(5):512-7. PubMed ID: 10229227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of human immunodeficiency virus type-1 from HIV-1 seropositive cases with undetectable viremia.
    Yang C; Li M; Cowart F; Rudolph D; Parekh B; McDougal JS; Lal RB
    J Clin Virol; 2004 Jul; 30(3):224-8. PubMed ID: 15135739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study).
    Lamine A; Caumont-Sarcos A; Chaix ML; Saez-Cirion A; Rouzioux C; Delfraissy JF; Pancino G; Lambotte O
    AIDS; 2007 May; 21(8):1043-5. PubMed ID: 17457100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Both human immunodeficiency virus cellular DNA sequencing and plasma RNA sequencing are useful for detection of drug resistance mutations in blood samples from antiretroviral-drug-naive patients.
    Parisi SG; Boldrin C; Cruciani M; Nicolini G; Cerbaro I; Manfrin V; Dal Bello F; Franchin E; Franzetti M; Rossi MC; Cattelan AM; Romano L; Zazzi M; Andreoni M; Palù G
    J Clin Microbiol; 2007 Jun; 45(6):1783-8. PubMed ID: 17442799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diverse pattern of protease inhibitor resistance mutations in HIV-1 infected patients failing nelfinavir.
    Svedhem V; Lindkvist A; Bergroth T; Knut L; Sönnerborg A
    J Med Virol; 2005 Aug; 76(4):447-51. PubMed ID: 15977242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.
    Puertas MC; Noguera-Julian M; Massanella M; Pou C; Buzon MJ; Clotet B; Stevenson M; Paredes R; Blanco J; Martinez-Picado J
    Retrovirology; 2016 Aug; 13(1):51. PubMed ID: 27484989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients.
    Monie D; Simmons RP; Nettles RE; Kieffer TL; Zhou Y; Zhang H; Karmon S; Ingersoll R; Chadwick K; Zhang H; Margolick JB; Quinn TC; Ray SC; Wind-Rotolo M; Miller M; Persaud D; Siliciano RF
    J Virol; 2005 Apr; 79(8):5185-202. PubMed ID: 15795302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy.
    Machado ES; Lambert JS; Watson DC; Afonso AO; da Cunha SM; Nogueira SA; Caride E; Oliveira RH; Sill AM; DeVico A; Tanuri A
    J Clin Virol; 2004 May; 30(1):24-31. PubMed ID: 15072750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strong cell-mediated immune responses are associated with the maintenance of low-level viremia in antiretroviral-treated individuals with drug-resistant human immunodeficiency virus type 1.
    Deeks SG; Martin JN; Sinclair E; Harris J; Neilands TB; Maecker HT; Hagos E; Wrin T; Petropoulos CJ; Bredt B; McCune JM
    J Infect Dis; 2004 Jan; 189(2):312-21. PubMed ID: 14722897
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
    AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-1 drug resistance in variants from the female genital tract and plasma.
    Kemal KS; Burger H; Mayers D; Anastos K; Foley B; Kitchen C; Huggins P; Schroeder T; Picchio G; Back S; Gao W; Meyer WA; Weiser B
    J Infect Dis; 2007 Feb; 195(4):535-45. PubMed ID: 17230413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
    Spudich SS; Huang W; Nilsson AC; Petropoulos CJ; Liegler TJ; Whitcomb JM; Price RW
    J Infect Dis; 2005 Mar; 191(6):890-8. PubMed ID: 15717264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells.
    Siliciano JD; Kajdas J; Finzi D; Quinn TC; Chadwick K; Margolick JB; Kovacs C; Gange SJ; Siliciano RF
    Nat Med; 2003 Jun; 9(6):727-8. PubMed ID: 12754504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.
    Wong JK; Hezareh M; Günthard HF; Havlir DV; Ignacio CC; Spina CA; Richman DD
    Science; 1997 Nov; 278(5341):1291-5. PubMed ID: 9360926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in circulating CD4+ T cells.
    Bailey JR; Sedaghat AR; Kieffer T; Brennan T; Lee PK; Wind-Rotolo M; Haggerty CM; Kamireddi AR; Liu Y; Lee J; Persaud D; Gallant JE; Cofrancesco J; Quinn TC; Wilke CO; Ray SC; Siliciano JD; Nettles RE; Siliciano RF
    J Virol; 2006 Jul; 80(13):6441-57. PubMed ID: 16775332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Both R5 and X4 human immunodeficiency virus type 1 variants persist during prolonged therapy with five antiretroviral drugs.
    van Rij RP; Visser JA; van Praag RM; Rientsma R; Prins JM; Lange JM; Schuitemaker H
    J Virol; 2002 Mar; 76(6):3054-8. PubMed ID: 11861873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re-emergence of HIV after stopping therapy.
    Chun TW; Davey RT; Engel D; Lane HC; Fauci AS
    Nature; 1999 Oct; 401(6756):874-5. PubMed ID: 10553903
    [No Abstract]   [Full Text] [Related]  

  • 40. Novel assay reveals a large, inducible, replication-competent HIV-1 reservoir in resting CD4
    Sanyal A; Mailliard RB; Rinaldo CR; Ratner D; Ding M; Chen Y; Zerbato JM; Giacobbi NS; Venkatachari NJ; Patterson BK; Chargin A; Sluis-Cremer N; Gupta P
    Nat Med; 2017 Jul; 23(7):885-889. PubMed ID: 28553933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.